Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2005-10-18
2005-10-18
Wessendorf, T. D. (Department: 1639)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
C435S173300, C435S173300, C435S235100, C536S023400
Reexamination Certificate
active
06956113
ABSTRACT:
The present invention relates to novel assays for assessing the degree to which a cell is metabolically active. Also provided, are mutagenicity assays and, more specifically, methods for determining whether a given agent is genotoxic. Embodiments of the assays employ a microorganism, or a mammalian cell, that has been genetically modified to produce light when the presence of test agent results in a mutation, e.g., reversion or forward, in the DNA of such microorganism or cell.
REFERENCES:
patent: WO 9303179 (1993-02-01), None
patent: WO 9413831 (1994-06-01), None
patent: WO 94/13831 (1994-08-01), None
patent: WO 9616187 (1996-05-01), None
patent: WO 9821347 (1998-05-01), None
Ames, B.N. et al., “Carcinogens are mutagens: a simple test system combining liver homogenates for activation and bacteria for detection,”Proc. Natl. Acad. Sci. USA70: 2281-2285 (1973a)(co-incubation of a carcinogen, a rat or human liver homogenate, and the bacterial tester strain on a petri plate).
Ames, B.N. et al., Methods for detecting carcinogens and mutagens withSalmonella/mammalian-microsome mutagenicity test,Mutation Res.31: 347-364 (1975).
Brooks, T.M., “The use of a streamlined bacterial mutagenicity assay, the MINISCREEN,”Mutagenesis10(5): 447-448 (1995).
de Lorenzo, V., et al., “Mini-Tn5 transposon derivatives for insertion mutagenesis, promoter probing, and chromosomal insertion of cloned DNA in gram-negative eubacteria,”J. Bacteriol.172(11): 6568-65 (1990).
Falck, K., et al., “Mutascreen®, an automated bacterial mutagenicity assay,”Mutation Res.150: 119-125 (1985).
Gee, P. et al., “Detection and classification of mutagens: A base set of base-specificSalmonellatester strains,”Proc. Natl. Acad. Sci. USA91: 11606-11610 (1994).
Green, M.H.L. & Muriel, W.J., “Mutagen testing using Trp reversion inEscherichia coli,” Mutation Res.38: 3-32 (1976).
Haworth, S., et al., “Salmonellamutagenicity results for 250 chemicals,”Environ. Mutagen.5(Suppl. 1): 3-142 (1983).
Houk, V.S. et al., “Development and validation of the spiralSalmonellaassay: An automated approach to bacterial mutagenicity testing,”Mutation Res.223: 49-64 (1989)(dose-response data is generated from a continuous concentration gradient on a single agar plate).
Johnston, T.C. et al., “The nucleotide sequence of the luxA and luxB genes ofXenorhabdus luminescensHM and a comparison of the amino acid sequences of luciferases from four species of bioluminescent bacteria,”BBRC170: 407-415 (1990).
Kado, N.Y. et al., “A simple modification of theSalmonellaliquid incubation assay: increased sensitivity for detecting mutagens in human urine,”Mutat. Res.112:25-32 (1983).
Marincs, F. & White, D.W.R., “Immobilization ofEscherichia coliExpressing the lux Genes ofXenorhabdus luminescens,” Appl. Environ. Microbiol.60(10): 3862-3863 (1994).
Maron, D.M. and Ames, B.N., “Revised methods for theSalmonellamutagenicity test,”Mutation Res.113: 173-215 (1983).
McCann, J. et al., “Detection of carcinogens as mutagens: bacterial tester strains with R factor plasmids,”Proc. Natl. Acad. Sci. USA72(3): 979-983 (1975).
McPherson, M.F. and Nestmann, E.R., “The SIMULTEST approach for testing mutagens in theSalmonellamicrotitre fluctuation assay,”Environ. Mol. Mutagen.16: 21-25 (1990).
Skulachev, V.P., “The sodium cycle: a novel type of bacterial energetics,”J. Bioenerg. Biomembr.21(6): 635-647 (1989).
Szittner, R. & Meighen, “Nucleotide sequence, expression and properties of luciferase coded by lux genes from a terrestrial bacterium,”JBC265: 16581-16587 (1990).
Voisey, C.R. & Marincs, F., “Elimination of Internal Restriction Enzyme Sites from a Bacterial Luminescence(luxCDABE) Operon,”Bio Techniques24:56-58 (1998).
Walker, G.C., “Plasmid (pkM101)-mediated enhancement of repair and mutagenesis: dependence on chromosomal genes inEscherichia coliK-12,”Mol. Gen. Gent.152(1): 93-103 (1977).
Xi, L. et al., “Cloning and nucleotide sequences of lux genes and characterization of luciferase ofXenorhabdus luminescensfrom a human wound,”J. Bacteriol.173: 1399-1405 (1991).
C. Côte et al., Mutation Research, 1995, vol. 345, pp 137-146, “A miniaturized Ames mutagenicity assay employing bioluminescent strains ofSalmonellatyphimurium”.
P. Billard et al., Clinical Biochemistry, 1998, vol. 31, pp 1-14, “Bioluminescence-based assays for detection and characterization of bacteria and chemicals in clinical laborators”.
Aubrecht Jiri
Ku Warren W.
Osowski Jeffery J.
Benson Gregg C.
Kleiman Gabriel L.
Pfizer Inc.
Richardson Peter C.
Wessendorf T. D.
LandOfFree
Bioluminescent assays and bacterial strains useful therein does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Bioluminescent assays and bacterial strains useful therein, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bioluminescent assays and bacterial strains useful therein will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3435268